Pfizer continues it's post-COVID vaccine foray into investment and expansion with venture capital firm Flagship for the development of up to 10 new drugs. The companies announced that they would initially invest $100 million.
According to STAT, Pfizer will have first dibs on each drug for up to $700 million plus royalties and...
